- Home
- DXST vs CDIO Comparison
DXST vs CDIO Comparison
Compare DXST & CDIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DXST
- CDIO
- Stock Information
- Founded
- DXST 2011
- CDIO 2017
- Country
- DXST China
- CDIO United States
- Employees
- DXST N/A
- CDIO N/A
- Industry
- DXST
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- Sector
- DXST
- CDIO Health Care
- Exchange
- DXST NYSE
- CDIO Nasdaq
- Market Cap
- DXST 18.7M
- CDIO 19.5M
- IPO Year
- DXST 2025
- CDIO N/A
- Fundamental
- Price
- DXST $1.01
- CDIO $0.48
- Analyst Decision
- DXST
- CDIO Buy
- Analyst Count
- DXST 0
- CDIO 1
- Target Price
- DXST N/A
- CDIO $2.00
- AVG Volume (30 Days)
- DXST 35.1K
- CDIO 901.3K
- Earning Date
- DXST 01-01-0001
- CDIO 05-14-2025
- Dividend Yield
- DXST N/A
- CDIO N/A
- EPS Growth
- DXST 13.11
- CDIO N/A
- EPS
- DXST 0.14
- CDIO N/A
- Revenue
- DXST $11,542,292.00
- CDIO $34,890.00
- Revenue This Year
- DXST N/A
- CDIO $1,434.82
- Revenue Next Year
- DXST N/A
- CDIO $4,661.91
- P/E Ratio
- DXST $7.20
- CDIO N/A
- Revenue Growth
- DXST 22.18
- CDIO 104.45
- 52 Week Low
- DXST $0.85
- CDIO $0.19
- 52 Week High
- DXST $5.74
- CDIO $1.77
- Technical
- Relative Strength Index (RSI)
- DXST N/A
- CDIO 59.66
- Support Level
- DXST N/A
- CDIO $0.30
- Resistance Level
- DXST N/A
- CDIO $0.58
- Average True Range (ATR)
- DXST 0.00
- CDIO 0.06
- MACD
- DXST 0.00
- CDIO 0.02
- Stochastic Oscillator
- DXST 0.00
- CDIO 68.00
About DXST DECENT HOLDING INC
Decent Holding Inc through its subsidiary specializes in the provision of wastewater treatment by cleansing the industrial wastewater, ecological river restoration and river ecosystem management by enhancing the water quality, as well as microbial products used for pollutant removal and water quality enhancement. Its main services and products include (1) wastewater treatment, (2) river water quality management, and (3) microbial products for water quality enhancement and pollutant cleansing purposes. The company's focus is on research and development (R&D) to sharpen its innovation edge.
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.